Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1939 | 2349 | 35.1 | 72% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1458 | 7272 | CHILDHOOD CANCER//FERTILITY PRESERVATION//LATE EFFECTS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FERTILITY PRESERVATION | Author keyword | 159 | 40% | 13% | 307 |
| 2 | OVARIAN TRANSPOSITION | Author keyword | 87 | 83% | 2% | 49 |
| 3 | GONADOTOXICITY | Author keyword | 80 | 78% | 2% | 53 |
| 4 | ONCOFERTILITY | Author keyword | 70 | 78% | 2% | 46 |
| 5 | SPERM BANKING | Author keyword | 48 | 77% | 1% | 33 |
| 6 | CHEMOTHERAPY INDUCED AMENORRHEA | Author keyword | 21 | 85% | 0% | 11 |
| 7 | GONADAL TOXICITY | Author keyword | 21 | 85% | 0% | 11 |
| 8 | FERTIL P ERVAT | Address | 18 | 59% | 1% | 20 |
| 9 | OVARIAN FAILURE | Author keyword | 13 | 26% | 2% | 44 |
| 10 | OVARIAN PROTECTION | Author keyword | 12 | 75% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | FERTILITY PRESERVATION | 159 | 40% | 13% | 307 | Search FERTILITY+PRESERVATION | Search FERTILITY+PRESERVATION |
| 2 | OVARIAN TRANSPOSITION | 87 | 83% | 2% | 49 | Search OVARIAN+TRANSPOSITION | Search OVARIAN+TRANSPOSITION |
| 3 | GONADOTOXICITY | 80 | 78% | 2% | 53 | Search GONADOTOXICITY | Search GONADOTOXICITY |
| 4 | ONCOFERTILITY | 70 | 78% | 2% | 46 | Search ONCOFERTILITY | Search ONCOFERTILITY |
| 5 | SPERM BANKING | 48 | 77% | 1% | 33 | Search SPERM+BANKING | Search SPERM+BANKING |
| 6 | CHEMOTHERAPY INDUCED AMENORRHEA | 21 | 85% | 0% | 11 | Search CHEMOTHERAPY+INDUCED+AMENORRHEA | Search CHEMOTHERAPY+INDUCED+AMENORRHEA |
| 7 | GONADAL TOXICITY | 21 | 85% | 0% | 11 | Search GONADAL+TOXICITY | Search GONADAL+TOXICITY |
| 8 | OVARIAN FAILURE | 13 | 26% | 2% | 44 | Search OVARIAN+FAILURE | Search OVARIAN+FAILURE |
| 9 | OVARIAN PROTECTION | 12 | 75% | 0% | 9 | Search OVARIAN+PROTECTION | Search OVARIAN+PROTECTION |
| 10 | SEMEN CRYOPRESERVATION | 9 | 28% | 1% | 26 | Search SEMEN+CRYOPRESERVATION | Search SEMEN+CRYOPRESERVATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SPERM BANKING | 105 | 87% | 2% | 52 |
| 2 | FERTILITY PRESERVATION | 103 | 35% | 10% | 242 |
| 3 | CRYOPRESERVED OVARIAN TISSUE | 83 | 53% | 5% | 111 |
| 4 | GONADAL FUNCTION | 76 | 33% | 8% | 188 |
| 5 | EMBRYO CRYOPRESERVATION | 49 | 54% | 3% | 62 |
| 6 | GONADAL DAMAGE | 42 | 70% | 1% | 35 |
| 7 | CHEMOTHERAPY INDUCED AMENORRHEA | 32 | 88% | 1% | 15 |
| 8 | INDUCED GONADOTOXICITY | 32 | 88% | 1% | 15 |
| 9 | FUNCTION FOLLOWING CHEMOTHERAPY | 31 | 74% | 1% | 23 |
| 10 | INDUCED OVARIAN DAMAGE | 24 | 91% | 0% | 10 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY | 1 | 12% | 0% | 11 |
| 2 | JOURNAL OF CANCER SURVIVORSHIP-RESEARCH AND PRACTICE | 1 | 12% | 0% | 8 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials | 2014 | 18 | 32 | 78% |
| American Society of Clinical Oncology recommendations on fertility preservation in cancer patients | 2006 | 652 | 131 | 58% |
| Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy | 2015 | 2 | 82 | 55% |
| Infertility in Reproductive-Age Female Cancer Survivors | 2015 | 1 | 53 | 70% |
| Current Concepts: Preservation of Fertility in Patients with Cancer. | 2009 | 159 | 57 | 53% |
| Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis | 2012 | 41 | 36 | 67% |
| Uses of anti-Mullerian hormone (AMH) measurement before and after cancer treatment in women | 2015 | 1 | 52 | 60% |
| Fertility preservation for young patients with cancer: who is at risk and what can be offered? | 2005 | 272 | 64 | 59% |
| Fertility preservation in patients receiving cyclophosphamide therapy for renal disease | 2015 | 1 | 35 | 57% |
| How do chemotherapeutic agents damage the ovary? | 2012 | 51 | 82 | 49% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FERTIL P ERVAT | 18 | 59% | 0.9% | 20 |
| 2 | MOL REPROD FERTIL P ERVAT | 9 | 67% | 0.3% | 8 |
| 3 | FERTIL REPROD MED S | 5 | 55% | 0.3% | 6 |
| 4 | SECT CHILD LIFE HLTH | 4 | 28% | 0.5% | 11 |
| 5 | MOL REPROD FERTIL P ERVAT OBSTET GYNECO | 3 | 100% | 0.1% | 3 |
| 6 | ONCOFERTIL CONSORTIUM | 3 | 50% | 0.2% | 4 |
| 7 | POLE GYNECOL OBSTET REPROD | 3 | 50% | 0.2% | 4 |
| 8 | SS SVILUPPO TER IE INNOVAT | 3 | 60% | 0.1% | 3 |
| 9 | FERTIL REPROD HLTH | 3 | 42% | 0.2% | 5 |
| 10 | AIDE PROCREAT CECOS | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000192338 | PREANTRAL FOLLICLES//PREANTRAL FOLLICLE//OVARIAN TISSUE |
| 2 | 0.0000107236 | ENDOCRINE LATE EFFECTS//GROWTH REPROD 5064//CRANIAL IRRADIATION |
| 3 | 0.0000073245 | SPERMATOGONIAL STEM CELLS//SPERMATOGONIAL STEM CELL//SPERMATOGONIA |
| 4 | 0.0000072554 | PREGNANCY ASSOCIATED BREAST CANCER//LACTATING ADENOMA//BREAST CANCER DURING PREGNANCY |
| 5 | 0.0000062520 | OVARIAN RESERVE//ANTI MULLERIAN HORMONE//ANTRAL FOLLICLE COUNT |
| 6 | 0.0000061337 | PATERNAL ALCOHOL//MALE MEDIATED EFFECTS//UNITE BIOL REPROD ASSISTANCE MED PROCREAT |
| 7 | 0.0000052471 | VERY YOUNG WOMEN//YOUNG BREAST CANCER//YOUNG AGE |
| 8 | 0.0000046513 | VITRIFICATION//OOCYTE CRYOPRESERVATION//SLOW FREEZING |
| 9 | 0.0000043802 | CHILDHOOD CANCER//CHILDHOOD CANCER SURVIVORS//JOURNAL OF PEDIATRIC ONCOLOGY NURSING |
| 10 | 0.0000043306 | TESTICULAR CANCER//RETROPERITONEAL LYMPH NODE DISSECTION//SEMINOMA |